{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-165344","form_type":"8-K","ticker":"RGEN","cik":"0000730272","company_name":"REPLIGEN CORP","filed_at":"2022-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.505966+00:00","generated_at":"2026-06-25T05:39:53.882524+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Repligen appoints Dr. Konstantin Konstantinov to board; all directors re-elected at annual meeting","bullets":["Konstantinov elected to board effective May 26, 2022; brings 30 years of bioprocessing expertise from Genzyme and Bayer.","Annual meeting results: all six director nominees elected with >94% support; Ernst & Young ratified as auditor; say-on-pay approved.","Severance and change in control plan amended to adjust treatment of performance-based equity awards upon change in control.","CEO Tony Hunt's employment agreement amended to align equity treatment with the amended severance plan.","Director compensation policy amended for new non-employee director equity grants; new director granted initial option worth $170,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-165344","json":"https://secwatch.observer/filing/0001193125-22-165344.json","markdown":"https://secwatch.observer/filing/0001193125-22-165344.md","text":"https://secwatch.observer/filing/0001193125-22-165344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730272/000119312522165344/0001193125-22-165344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730272/000119312522165344/d339987d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:39:53.882524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"917662fe36","claim":"Konstantin Konstantinov was elected as Director at REPLIGEN CORP.","evidence_excerpt":"the Board elected Konstantin Konstantinov, Ph.D. to the Board, effective May 26, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/730272/000119312522165344/0001193125-22-165344-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}